ZA811304B - Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide - Google Patents

Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide

Info

Publication number
ZA811304B
ZA811304B ZA00811304A ZA811304A ZA811304B ZA 811304 B ZA811304 B ZA 811304B ZA 00811304 A ZA00811304 A ZA 00811304A ZA 811304 A ZA811304 A ZA 811304A ZA 811304 B ZA811304 B ZA 811304B
Authority
ZA
South Africa
Prior art keywords
acridinylamino
anisidide
methanesulfon
pharmaceutical salts
pharmaceutical
Prior art date
Application number
ZA00811304A
Other languages
English (en)
Inventor
James R Fisher
Charles P Kulier
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA811304B publication Critical patent/ZA811304B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C07H7/033—Uronic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C07H7/027—Keto-aldonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA00811304A 1980-03-11 1981-02-06 Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide ZA811304B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12950380A 1980-03-11 1980-03-11

Publications (1)

Publication Number Publication Date
ZA811304B true ZA811304B (en) 1982-06-30

Family

ID=22440294

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00811304A ZA811304B (en) 1980-03-11 1981-02-06 Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide

Country Status (16)

Country Link
EP (1) EP0035862B1 (ja)
JP (1) JPS56142265A (ja)
KR (1) KR840001561B1 (ja)
AR (1) AR225346A1 (ja)
AT (1) ATE7911T1 (ja)
AU (1) AU535610B2 (ja)
CA (1) CA1253160A (ja)
DE (1) DE3164054D1 (ja)
DK (1) DK161072C (ja)
ES (1) ES8202332A1 (ja)
HU (1) HU183357B (ja)
IE (1) IE50967B1 (ja)
MX (1) MX6764E (ja)
NZ (1) NZ196461A (ja)
SU (1) SU1192619A3 (ja)
ZA (1) ZA811304B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322424A (en) * 1980-01-24 1982-03-30 Bristol-Myers Company Crystalline glucoconate salt of m-AMSA and compositions containing same
ES512969A0 (es) * 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid
DE3809814C1 (en) * 1988-03-23 1989-09-07 Karl Heinz Dr.Med. 7100 Heilbronn De Thiel Use of aminoacridines for iontophoretic treatment of bladder cancer
CA3209229A1 (en) * 2017-11-09 2019-05-16 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Compounds for inhibiting ly6k and methods of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1674923A (en) * 1924-04-12 1928-06-26 Schnorf Carl Process for the production of carbohydrate-acridine compounds and solutions thereof
DE3063905D1 (en) * 1979-09-14 1983-07-28 New Zealand Dev Finance Compounds having antitumour properties, process for their preparation, these compounds for use as antitumour agents and pharmaceutical compositions containing them
JPS5687566A (en) * 1979-11-30 1981-07-16 Bristol Myers Co Anticancerous composition
ZA81420B (en) * 1980-01-24 1982-02-24 Bristol Myers Co Antitumor compositions

Also Published As

Publication number Publication date
KR830005149A (ko) 1983-08-03
ATE7911T1 (de) 1984-06-15
ES500228A0 (es) 1982-01-16
MX6764E (es) 1986-06-30
JPH0343269B2 (ja) 1991-07-01
ES8202332A1 (es) 1982-01-16
AR225346A1 (es) 1982-03-15
EP0035862A3 (en) 1981-11-18
HU183357B (en) 1984-04-28
EP0035862B1 (en) 1984-06-13
AU535610B2 (en) 1984-03-29
SU1192619A3 (ru) 1985-11-15
DE3164054D1 (en) 1984-07-19
JPS56142265A (en) 1981-11-06
IE810396L (en) 1981-09-11
NZ196461A (en) 1982-12-21
IE50967B1 (en) 1986-08-20
EP0035862A2 (en) 1981-09-16
DK161072C (da) 1991-11-11
AU6819281A (en) 1981-09-17
DK161072B (da) 1991-05-27
CA1253160A (en) 1989-04-25
DK109181A (da) 1981-09-12
KR840001561B1 (ko) 1984-10-05

Similar Documents

Publication Publication Date Title
DE3476388D1 (en) Derivatives of 2,2'-iminobisethanol
ZA816817B (en) N-thiazolylmethylthioalkyl-n'-alkylamidines and related compounds
GB8408815D0 (en) Derivatives of azet-2-ones
JPS57144219A (en) Azobissalicylic acid and salts thereof and medicinal composition containing them
GB2078220B (en) Penem-3-carboxylic acid derivatives and their preparation
ZA817796B (en) Use of anticholenergic drugs
ZA811304B (en) Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide
DE3466389D1 (en) Novel pharmaceutical compounds and their preparation
GB2083464B (en) N-methanesulfonic acid derivatives of istamycin a or b andproduction thereof
CU21474A (en) Phenylpropargylamine's derivatives
IL61928A (en) Preparation of alpha-ketocarboxylic acid n-tert.-butylamides
DE3360020D1 (en) Fungicide-active derivatives of benzhydrole
GB8402836D0 (en) 3-o-acyl-4"-deoxy-desmycosin derivatives
JPS57142258A (en) Drug containing tape preparation
DE3479209D1 (en) Salts of antimalarial phenanthrenemethanol compounds
GB2086890B (en) Derivatives of 2-(2'-oxo-ethylidene)-3-clavancarboxylic acid
ZA847255B (en) Salts of antimalarial phenanthrenemethanol
GB2079750B (en) 3 aminopropoxyphenyl derivatives their preparation and pharmaceutical compositions containing them
IL62026A0 (en) Calcitronic acid derivatives and related compounds
ZA879599B (en) The separation of sodium salts
IL73845A (en) Calcitroic acid derivatives and related compounds
IL73845A0 (en) Calcitroic acid derivatives and related compounds
BG40991A1 (en) Medicinal form containing trans- 1- benzhydryl- 4- cynamylpiperazine or its derivatives
JPS57110196A (en) Preparation of thimocin alpha 1
GB8329750D0 (en) 5-phenoxybenzoic acid derivatives of pentites